Featured Research

from universities, journals, and other organizations

Is Rheumatoid Arthritis Becoming Milder?

Date:
September 3, 2005
Source:
John Wiley & Sons, Inc.
Summary:
Is the course of rheumatoid arthritis becoming milder? If so, why? Intrigued by these questions, researchers in The Netherlands decided to seek out the answers through a rigorous investigation.

Rheumatoid arthritis (RA) is a chronic inflammatory disease, markedwith joint pain and erosion. The course of RA can vary considerably,from mild to crippling, and is difficult to predict. On the strength ofpatient case histories and clinical trials, rheumatologists havesuggested that the majority of today's RA patients are suffering lesssevere symptoms and less functional disability compared with RApatients in past decades.

Is the course of RA becoming milder? If so, why? Intrigued by thesequestions, researchers in The Netherlands decided to seek out theanswers through a rigorous investigation. Published in the September2005 issue of Arthritis & Rheumatism (http://www.interscience.wiley.com/journal/arthritis),their findings indicate a positive trend. "Patients with early RApresenting in recent years have less severe disease activity atpresentation, as well as a more favorable course of their disease,compared with patients in earlier years," states the study's leadingauthor, Paco M. J. Welsing, MSc.

What is the reason for this improving trend? Welsing and his colleaguesfound no clear, conclusive cause, and even uncovered some contradictoryevidence. However, the team found a concurrent tendency toward ashorter duration of symptoms at the time of diagnosis and moreaggressive use of drug therapy--for instance, methotrexate, today'spreferred disease-modifying anti-rheumatic drug (DMARD) and/orprednisone--over the course of the disease.

The study included all newly diagnosed, early RA patientsenrolled in the department of rheumatology clinic of Radboud UniversityNijmegen Medical Centre since 1985. Patients were divided into fourgroups based on the date of enrollment. Patients enrolled between 1985and 1990 (167 total) comprised Group 1. Patients enrolled between 1990and 1995 (132 total) comprised Group 2. Patients enrolled between 1995and 2000 (114 total) comprised Group 3. And patients enrolled between2000 and 2005 (112 total) comprised Group 4. In all groups, themajority of patients were women. The mean age at the time of enrollmentwas 54 years for Group 1; 55 years for both Groups 2 and 3; and 57years for group 4.

Researchers set out to compare disease activity and functionaldisability among the groups over a 5-year progression (but 4-years,maximum, for Group 4). They also compared treatment strategies amongthe groups. All patients were assessed for signs of RAactivity--namely, swelling and tenderness--in 28 joints every 3 months,a laboratory measure for inflammation and a measure of general wellbeing by the Disease Activity Score 28 (DAS28). All patients wereassessed for functional disability--covering difficulties with walkingand conducting everyday activities--using the Health AssessmentQuestionnaire disability index (HAQ DI) every 6 months. In addition,all patients were periodically evaluated for pain in general.

The DAS28 scores at baseline and over the course of the studywere consistently lower, indicating milder disease activity, in themore recent groups--that is, patients diagnosed with RA within the lastten years. At the 5-year culmination, the DAS28 scores were lowest inthe most recent, complete group--Group 3, patients diagnosed between1995 and 2000--compared with both Group 2 (1990-1995) and Group 1(1985-1990). The average disease activity over time per patient showedsimilar trends of improvement. The average DAS28 score improved from4.1 to 3.4 from the Group 1 to Group 3.

However, the HAQ DI scores at baseline and over time were notlower among patients enrolled later in the study, and even showed someevidence of a worsening trend. "This contradictory result may be partlya distinction between measures of physical examination, laboratoryresults, and patient-assessed outcomes," notes Welsing, "which can beinfluenced by internal standards or attitudes of patients."

Researchers did find a correlation between more aggressivetreatment strategies and milder disease activity in the more recentgroups of patients. While suggesting the effectiveness of earlytreatment with methotrexate, for instance, and/or prednisone formanaging RA's symptoms and destructive progression, this connectioncalls for further investigation.

###

Article: "Is the DiseaseCourse of Rheumatoid Arthritis Becoming Milder? Time Trends Since 1985in an Inception Cohort of Early Rheumatoid Arthritis," Paco M. J.Welsing, Jaap Fransen, and Piet L. C. M. van Riel, Arthritis &Rheumatism, September 2005; 52:9; pp. 2616-2624.


Story Source:

The above story is based on materials provided by John Wiley & Sons, Inc.. Note: Materials may be edited for content and length.


Cite This Page:

John Wiley & Sons, Inc.. "Is Rheumatoid Arthritis Becoming Milder?." ScienceDaily. ScienceDaily, 3 September 2005. <www.sciencedaily.com/releases/2005/09/050902065747.htm>.
John Wiley & Sons, Inc.. (2005, September 3). Is Rheumatoid Arthritis Becoming Milder?. ScienceDaily. Retrieved September 2, 2014 from www.sciencedaily.com/releases/2005/09/050902065747.htm
John Wiley & Sons, Inc.. "Is Rheumatoid Arthritis Becoming Milder?." ScienceDaily. www.sciencedaily.com/releases/2005/09/050902065747.htm (accessed September 2, 2014).

Share This




More Health & Medicine News

Tuesday, September 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Snack Attack: Study Says Action Movies Make You Snack More

Snack Attack: Study Says Action Movies Make You Snack More

Newsy (Sep. 2, 2014) You're more likely to gain weight while watching action flicks than you are watching other types of programming, says a new study published in JAMA. Video provided by Newsy
Powered by NewsLook.com
U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

Newsy (Sep. 2, 2014) The U.N. says the problem is two-fold — quarantine zones and travel restrictions are limiting the movement of both people and food. Video provided by Newsy
Powered by NewsLook.com
Doctors Fear They're Losing Battle Against Ebola

Doctors Fear They're Losing Battle Against Ebola

AP (Sep. 2, 2014) As a third American missionary is confirmed to have contracted Ebola in Liberia, doctors on the ground in West Africa fear they're losing the battle against the outbreak. (Sept. 2) Video provided by AP
Powered by NewsLook.com
Tech Giants Bet on 3D Headsets for Gaming, Healthcare

Tech Giants Bet on 3D Headsets for Gaming, Healthcare

AFP (Sep. 2, 2014) When Facebook acquired the virtual reality hardware developer Oculus VR in March for $2 billion, CEO Mark Zuckerberg hailed the firm's technology as "a new communication platform." Duration: 02:24 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins